Geneva Partners, LLC Pfizer Inc Transaction History

Geneva Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $686,089 - $770,320	-18,553 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $40,762 - $44,784	-1,087 Reduced 5.53%	18,553 $788,000
Q4 2018 Jan 30, 2019	BUY	$38.47 - $43.86 $333,765 - $380,529	8,676 Added 79.13%	19,640 $857,000
Q3 2018 Oct 23, 2018	BUY	$34.47 - $41.81 $377,929 - $458,404	10,964 New	10,964 $483,000

3,256

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.